Inhibitors of SARS-CoV entry – Identification using an internally-controlled dual envelope pseudovirion assay
- 26 July 2011
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 92 (2) , 187-194
- https://doi.org/10.1016/j.antiviral.2011.07.016
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune ResponseJournal of Virology, 2011
- Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusionVirology, 2011
- Cleavage of the SARS Coronavirus Spike Glycoprotein by Airway Proteases Enhances Virus Entry into Human Bronchial Epithelial Cells In VitroPLOS ONE, 2009
- Characterization of Chikungunya pseudotyped viruses: Identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoproteinVirology, 2009
- Identification of a Broad-Spectrum Arenavirus Entry InhibitorJournal of Virology, 2008
- pH-Induced Activation of Arenavirus Membrane Fusion Is Antagonized by Small-Molecule InhibitorsJournal of Virology, 2008
- Structural Basis for Potent Cross-Neutralizing Human Monoclonal Antibody Protection against Lethal Human and Zoonotic Severe Acute Respiratory Syndrome Coronavirus ChallengeJournal of Virology, 2008
- Natural Mutations in the Receptor Binding Domain of Spike Glycoprotein Determine the Reactivity of Cross-Neutralization between Palm Civet Coronavirus and Severe Acute Respiratory Syndrome CoronavirusJournal of Virology, 2007
- Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike VariantsPLoS Medicine, 2006
- Role of Endosomal Cathepsins in Entry Mediated by the Ebola Virus GlycoproteinJournal of Virology, 2006